Together, the significant correlations observed across multiple organ domains indicate that SS-A/Ro52 and SS-A/Ro60 may serve as markers of widespread immune activation in Kazakh SSc patients rather than being restricted to a single clinical subset. This evidence concerns the gene TRIM21 and systemic sclerosis.